No Prescription |
 |
 | ||
|
Dermovate scalp lotion Generic Clobetasol 17 propionate |
|
| ||
No Prescription » Prescription Drugs 5 » Dermovate scalp lotion Generic Clobetasol 17 propionate Product Origin: EU (Turkey) This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English. Medical Information: This medicine contains the active ingredient clobetasol propionate which is a type of medicine called a corticosteroid. Corticosteroids are medicines used for reducing inflammation. Inflammation of the skin happens due to irritation of the skin and is caused by the release of various substances that are important in the immune system. These substances cause blood vessels to widen resulting in the irritated area becoming red swollen itchy and painful. When clobetasol is applied to the skin it works by acting inside the skin cells to decrease the release of these inflammatory substances. This reduces swelling redness and itch. Clobetasol is a very potent corticosteroid that is applied to the skin to treat severe inflammatory skin disorders such as eczema and psoriasis that have not responded to milder steroids. This medicine contains clobetasol formulated as a scalp application which is thinner and easier to apply to the scalp than the clobetasol ointments and creams used on the rest of the body. It is used to treat severe inflammatory disorders of the scalp that have not responded to milder steroids. What is it used for? Eczema affecting the scalp unresponsive to weaker corticosteroids Psoriasis of the scalp Buy Dermovate scalp lotion Generic Clobetasol 17 propionate and other Prescription Drugs 5 products online at Medstore. 4953
About Dermovate scalp lotion Generic Clobetasol 17 propionate: Product Type: Prescription Drugs 5 Dermovate scalp lotion ( Generic Clobetasol 17-propionate ) Dermovate scalp lotion (Generic Clobetasol 17-propionate) Generic Clobetasol 17-propionate 0 05% a/a 25 ml Generic Clobetasol 17-propionate Dermovate scalp lotion
View more Prescription Drugs 5 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
